Wade Ackerman

(Gittings Photography/Jeff Lewis)

Partner | Covington & Burling LLP
Harvard Law School
Life Sciences & Healthcare

Wade Ackerman, a partner at Covington & Burling LLP, leverages two decades of experience in private practice, the FDA and Capitol Hill to guide clients through complex regulatory challenges. He co-leads Covington’s Digital Health Initiative, advising on legal, regulatory and policy issues in digital health. Ackerman played a key role in modernizing the FDA’s cosmetics regulation, negotiating the reform enacted in 2022 and now leading industry implementation efforts. He serves as outside counsel for Accumulus Synergy, advising on global regulatory technology solutions and leads the RWE Alliance’s engagement with the FDA and Congress on real-world evidence use. Additionally, he advises Johnson & Johnson on federal policy, including OTC drug reforms under the CARES Act. Ackerman sits on the boards of the Keck Graduate Institute and the Williams Institute at UCLA Law.